Vector Blog

Pediatric brain tumor genomics arrives, as the need for new therapies grows

Precision cancer medicine – the vision of tailoring diagnosis and treatments to a tumor’s genetic susceptibilities – is now ready to impact the care of a majority of children with brain tumors. It’s led, for example, to a current clinical trial testing the anti-melanoma drug dabrafenib in a variety of brain tumors with the same BRAF mutation – including metastatic...

The post Pediatric brain tumor genomics arrives, as the need for new therapies grows appeared first on Vector.

Soft robot could aid failing hearts by mimicking healthy cardiac muscle

heart-failure

Every year, about 2,100 people receive heart transplants in the U.S., while 5.7 million suffer from heart failure. Given the scarcity of available donor hearts, clinicians and biomedical engineers from Boston Children’s Hospital and Harvard University have spent several years developing a mechanical alternative. Their proof of concept is reported today in Science Translational Medicine:...

The post Soft robot could aid failing hearts by mimicking healthy cardiac muscle appeared first on Vector.

Who We are

The mission of the Technology and Innovation Development Office (TIDO) to maximize the impact of Boston Children’s innovations on patient health while enhancing the research endeavor.

News and Events

Letters of Intent (LOI) are due on Feb. 8, 2017. To learn more about TDF, please join us for an informational lunch seminar on Wednesday, January 18, 2017, 12 - 1 pm in the Karp 7 Conference room. Pizza will be provided, so please RSVP to technoogy.development@childrens.harvard.edu.

Fiscal Year 2015 was a year of growth at TIDO. Boston Children’s executed 48 licenses, a 42 percent increase over the prior year, while the total number of executed industry research and license agreements reached 91, an increase of 17 percent over the prior year. The report highlights selected agreements, Technology Development Fund award winners, and some of our technologies available for licensing.

The new IP Policy allows for researchers to independently generate and complete certain outbound academic MTAs if specific criteria are met. In addition, we have implemented a new form for initiating inbound MTAs. Please click the link above for instructions and to download the forms.

@ChildrensTIDO on Twitter

Connect with us

youtube

Terms and Conditions children's hospital
Site Designed and Developed by Genuine